Circulating microRNAs as Biomarkers of COVID-19 Severity

L. Pinilla; I. Benítez; A. Carratalá; A. Moncusí-Moix; C. Gort-Paniello; M. Molinero; J. González; G. Torres; M. Bernal; S. Pico; C. Doncel; R. Almansa; N. Jorge; E. Bustamante; J. Gómez; M. González-Rivera; D. Micheloud; P. Ryan; L. Tamayo; C. Aldecoa; R. Ferrer; A. Ceccato; L. Fernández; A. Motos; J. Riera; R. Menéndez; D. García; O. Peñuelas; A. Torres; J. Bermejo-Martin; F. Barbé; D. de Gonzalo-Calvo

doi:10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2530

Circulating microRNAs as Biomarkers of COVID-19 Severity

L. Pinilla
, I. Benítez
, A. Carratalá
, A. Moncusí-Moix
, C. Gort-Paniello
, M. Molinero
, J. González
, G. Torres
, M. Bernal
, S. Pico
, C. Doncel
, R. Almansa
, N. Jorge
, E. Bustamante
, J. Gómez
, M. González-Rivera
, D. Micheloud
, P. Ryan
, L. Tamayo
, C. Aldecoa

R. Ferrer, A. Ceccato, L. Fernández, A. Motos, J. Riera, R. Menéndez, D. García, O. Peñuelas, A. Torres, J. Bermejo-Martin, F. Barbé, D. de Gonzalo-Calvo

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

RATIONALE: The identification of minimally invasive and easily-accessible biomarkers to support the management of coronavirus disease 2019 (COVID-19) in hospitalized patients constitutes a hot topic in clinical research. MicroRNAs (miRNAs) have been proposed as clinical indicators to assist in medical decision-making. Here, we aimed to examine the circulating miRNA profile of hospitalized COVID-19 patients and to evaluate its potential as a source of biomarkers for the management of the disease.

Original language	English
Pages (from-to)	A2530
Number of pages	1
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	203
DOIs	https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2530
Publication status	Published - May 2021
Externally published	Yes
Event	American Thoracic Society 2021 International Conference - Virtual Duration: 14 May 2021 → 19 May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

MicroRNA
coronavirus (COVID-19)
Biomarkers
Hospitalized patients

Access to Document

10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2530Licence: In Copyright

Cite this

Pinilla, L., Benítez, I., Carratalá, A., Moncusí-Moix, A., Gort-Paniello, C., Molinero, M., González, J., Torres, G., Bernal, M., Pico, S., Doncel, C., Almansa, R., Jorge, N., Bustamante, E., Gómez, J., González-Rivera, M., Micheloud, D., Ryan, P., Tamayo, L., ... de Gonzalo-Calvo, D. (2021). Circulating microRNAs as Biomarkers of COVID-19 Severity. American Journal of Respiratory and Critical Care Medicine, 203, A2530. https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2530

@article{309e7ae7e22c4fcdaf2697935cc20c10,

title = "Circulating microRNAs as Biomarkers of COVID-19 Severity",

abstract = "RATIONALE: The identification of minimally invasive and easily-accessible biomarkers to support the management of coronavirus disease 2019 (COVID-19) in hospitalized patients constitutes a hot topic in clinical research. MicroRNAs (miRNAs) have been proposed as clinical indicators to assist in medical decision-making. Here, we aimed to examine the circulating miRNA profile of hospitalized COVID-19 patients and to evaluate its potential as a source of biomarkers for the management of the disease. ",

keywords = "MicroRNA, coronavirus (COVID-19), Biomarkers, Hospitalized patients",

author = "L. Pinilla and I. Ben{\'i}tez and A. Carratal{\'a} and A. Moncus{\'i}-Moix and C. Gort-Paniello and M. Molinero and J. Gonz{\'a}lez and G. Torres and M. Bernal and S. Pico and C. Doncel and R. Almansa and N. Jorge and E. Bustamante and J. G{\'o}mez and M. Gonz{\'a}lez-Rivera and D. Micheloud and P. Ryan and L. Tamayo and C. Aldecoa and R. Ferrer and A. Ceccato and L. Fern{\'a}ndez and A. Motos and J. Riera and R. Men{\'e}ndez and D. Garc{\'i}a and O. Pe{\~n}uelas and A. Torres and J. Bermejo-Martin and F. Barb{\'e} and \{de Gonzalo-Calvo\}, D.",

year = "2021",

month = may,

doi = "10.1164/ajrccm-conference.2021.203.1\_MeetingAbstracts.A2530",

language = "English",

volume = "203",

pages = "A2530",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

note = "American Thoracic Society 2021 International Conference, ATS 2021 ; Conference date: 14-05-2021 Through 19-05-2021",

}

Pinilla, L, Benítez, I, Carratalá, A, Moncusí-Moix, A, Gort-Paniello, C, Molinero, M, González, J, Torres, G, Bernal, M, Pico, S, Doncel, C, Almansa, R, Jorge, N, Bustamante, E, Gómez, J, González-Rivera, M, Micheloud, D, Ryan, P, Tamayo, L, Aldecoa, C, Ferrer, R, Ceccato, A, Fernández, L, Motos, A, Riera, J, Menéndez, R, García, D, Peñuelas, O, Torres, A, Bermejo-Martin, J, Barbé, F & de Gonzalo-Calvo, D 2021, 'Circulating microRNAs as Biomarkers of COVID-19 Severity', American Journal of Respiratory and Critical Care Medicine, vol. 203, pp. A2530. https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2530

TY - JOUR

T1 - Circulating microRNAs as Biomarkers of COVID-19 Severity

AU - Pinilla, L.

AU - Benítez, I.

AU - Carratalá, A.

AU - Moncusí-Moix, A.

AU - Gort-Paniello, C.

AU - Molinero, M.

AU - González, J.

AU - Torres, G.

AU - Bernal, M.

AU - Pico, S.

AU - Doncel, C.

AU - Almansa, R.

AU - Jorge, N.

AU - Bustamante, E.

AU - Gómez, J.

AU - González-Rivera, M.

AU - Micheloud, D.

AU - Ryan, P.

AU - Tamayo, L.

AU - Aldecoa, C.

AU - Ferrer, R.

AU - Ceccato, A.

AU - Fernández, L.

AU - Motos, A.

AU - Riera, J.

AU - Menéndez, R.

AU - García, D.

AU - Peñuelas, O.

AU - Torres, A.

AU - Bermejo-Martin, J.

AU - Barbé, F.

AU - de Gonzalo-Calvo, D.

PY - 2021/5

Y1 - 2021/5

N2 - RATIONALE: The identification of minimally invasive and easily-accessible biomarkers to support the management of coronavirus disease 2019 (COVID-19) in hospitalized patients constitutes a hot topic in clinical research. MicroRNAs (miRNAs) have been proposed as clinical indicators to assist in medical decision-making. Here, we aimed to examine the circulating miRNA profile of hospitalized COVID-19 patients and to evaluate its potential as a source of biomarkers for the management of the disease.

AB - RATIONALE: The identification of minimally invasive and easily-accessible biomarkers to support the management of coronavirus disease 2019 (COVID-19) in hospitalized patients constitutes a hot topic in clinical research. MicroRNAs (miRNAs) have been proposed as clinical indicators to assist in medical decision-making. Here, we aimed to examine the circulating miRNA profile of hospitalized COVID-19 patients and to evaluate its potential as a source of biomarkers for the management of the disease.

KW - MicroRNA

KW - coronavirus (COVID-19)

KW - Biomarkers

KW - Hospitalized patients

U2 - 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2530

DO - 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2530

M3 - Meeting Abstract

SN - 1073-449X

VL - 203

SP - A2530

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

T2 - American Thoracic Society 2021 International Conference

Y2 - 14 May 2021 through 19 May 2021

ER -

Circulating microRNAs as Biomarkers of COVID-19 Severity

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this